Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Therapy areas
Psychiatry
Psychiatry
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psychiatry
Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
Biospace News
-
December 19, 2019
Psychiatry
Minerva Neurosciences scraps antidepressant drug candidate MIN-117 after failed mid-stage trial
Psychiatry
Axsome’s experimental drug AXS-05 hits main goal of late-stage major depressive disorder study
Psychiatry
Acadia details positive results from late-stage study of pimavanserin for dementia-related psychosis
Psychiatry
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
Psychiatry
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
0
Psychiatry
Alkermes to Present New Data From Mental Health Portfolio at the...
Biospace News
-
May 22, 2019
0
Psychiatry
Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the...
Firstwordpharma News
-
May 16, 2019
0
Psychiatry
Once-Daily Trazodone as Effective as Venlafaxine XR for Major Depressive Disorder:...
Firstwordpharma News
-
April 10, 2019
0
Psychiatry
Achieve Life Sciences Announces Successful Completion of the Second and Final...
Biospace News
-
April 2, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Epinephrine Nasal Spray Demonstrates Bioequivalent Exposure and Absorption Rate Compared to...
March 18, 2020
Abzena and Lipum AB Sign Integrated CMC Agreement to Produce a...
March 19, 2019
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief...
July 2, 2020
Injectable Peptide Might Help Spinal Cord Injury Patients Walk Again
May 14, 2019
Load more
HOT NEWS
Immuno-oncology
Odonate Therapeutics Announces Initiation of CONTESSA 2, a Phase 2 Study...
Commercial
Vivoryon Therapeutics Reports Third Quarter 2019
Others
Injectable Peptide Might Help Spinal Cord Injury Patients Walk Again
Approval
GSK Announces U.S. Food and Drug Administration Approval of Additional Indication...
